Miscellaneous Drugs and Male Reproduction

Adv Exp Med Biol. 2017:1034:211-226. doi: 10.1007/978-3-319-69535-8_13.

Abstract

In addition to main categories of medications believed to have negative impacts on male reproduction, there are a number of miscellaneous drugs with some evidence for such adverse reactions. Because of its widespread use and over-the-counter availability, the H2 receptor antagonist cimetidine is most concerning. As a competitive antagonist at androgen receptors, it can impact the HPG axis and semen quality. In this chapter, we review the studies of this drug and other histamine H2 receptor antagonists in men and experimental species. Several other medications are concerning and the evidence for negative effects on reproduction are covered: colchicine, domperidone, hydroxyurea, metformin, metoclopramide, mifepristone, retinoids, and statins.

Publication types

  • Review

MeSH terms

  • Animals
  • Cimetidine / adverse effects
  • Cimetidine / therapeutic use
  • Colchicine / adverse effects
  • Colchicine / therapeutic use
  • Domperidone / adverse effects
  • Domperidone / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use
  • Male
  • Metoclopramide / adverse effects
  • Metoclopramide / therapeutic use
  • Mifepristone / adverse effects
  • Mifepristone / therapeutic use
  • Reproduction / drug effects*
  • Retinoids / adverse effects
  • Retinoids / therapeutic use

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Retinoids
  • Mifepristone
  • Domperidone
  • Cimetidine
  • Metoclopramide
  • Colchicine
  • Hydroxyurea